Skip to content

Patents deal may benefit few

Tipranavir development plans announced

Call for access to cheaper monitoring

Hep C combinations show promise in HIV/HCV patients

TRIPS patent agreement: final text

Deal agreed on relaxing drug patents

China facing up to HIV epidemic

Nevirapine for all pregnant women may be more acceptable in Zambia

US backs down on generics for S Africa